Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tenon Medical (TNON) EBITDA Margin (2021 - 2025)

Tenon Medical has reported EBITDA Margin over the past 5 years, most recently at 191.22% for Q4 2025.

  • Quarterly results put EBITDA Margin at 191.22% for Q4 2025, up 20969.0% from a year ago — trailing twelve months through Dec 2025 was 318.36% (up 9748.0% YoY), and the annual figure for FY2025 was 318.36%, up 9748.0%.
  • EBITDA Margin for Q4 2025 was 191.22% at Tenon Medical, up from 284.65% in the prior quarter.
  • Over the last five years, EBITDA Margin for TNON hit a ceiling of 191.22% in Q4 2025 and a floor of 7568.18% in Q2 2021.
  • Median EBITDA Margin over the past 5 years was 536.32% (2023), compared with a mean of 1750.81%.
  • Biggest five-year swings in EBITDA Margin: tumbled -198075bps in 2022 and later soared 352618bps in 2023.
  • Tenon Medical's EBITDA Margin stood at 5424.53% in 2021, then soared by 48bps to 2829.24% in 2022, then surged by 87bps to 380.94% in 2023, then decreased by -5bps to 400.91% in 2024, then skyrocketed by 52bps to 191.22% in 2025.
  • The last three reported values for EBITDA Margin were 191.22% (Q4 2025), 284.65% (Q3 2025), and 490.96% (Q2 2025) per Business Quant data.